S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)

Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors

Monday, December 21, 2020 | Thomas Hughes
Factset Is Underloved And Outperforming

Factset Research Systems (NYSE:FDS) emerged as a buyable stock for me early in the pandemic because its revenue proved pandemic resistant, the stock was woefully underloved by the analysts, and it paid a very safe and growing dividend. Since then the stock has outperformed the market’s expectation, the sell-side market that is, and become a great play for contrarian investors. Now, with the FQ1 revenue and earnings in the bag, the stock is attractive as it ever was.

The average rating for this stock is Hold but with a decidedly bearish bias. Of the 12 current ratings, only 5 are neutral while 7 are bearish. Their consensus estimate is near the $290.00 level or about 16% below the current price range but take that with a grain of salt. The consensus price target has been edging higher since the summer gaining more than 18% and I expect it to continue rising. The most recent analysts calls came out in October after the last report, there will be more now, mark my words.

Factset Research Systems Beats The Consensus

Factset Research Systems has been having a good year. The company’s revenue growth slowed to about 2% in the calendar 2nd quarter but has since rebounded back to pre-COVID levels. The $388.2 million reported in the fiscal 1st/calendar 3rd quarter is up 5.9% YOY and 1.2% QoQ with YOY growth accelerating from the previous quarter to this. The revenue beat the consensus but by an admittedly small margin, about 0.15%.

The increase in revenue is due primarily to an increase in demand for analytics (go figure), content, and technology services (another no brainer). Organic revenue grew 5.1% with the remainder due to acquisitions and FX. The annual subscription value came in at $1.56 billion, in-line with consensus, and up from last year’s $1.48 billion.


“We have more conviction in our end markets than we did when we started the fiscal year,” said Phil Snow, FactSet CEO. “Our pipeline remains robust, built on the investments we are making in content and technology. The number and depth of conversations we are having with our largest clients around digital transformation, and how we can help streamline their workflows, position us well as we enter our second quarter.”

Moving down, the company’s margins expanded as well providing a lever for earnings. The adjusted operating margins grew 50 bps on a YOY basis to 34.3% due to reduced employment costs related to COVID-19. Unlike some other business types, Factset Research Systems is uniquely positioned to capture the bulk of potential savings from work at home trends. Market research can be done on the Internet from anywhere, just ask me, I know all about it. On the bottom line, the GAAP eps beat consensus by $0.03 while adjusted eps of $2.88 beat by $0.14.

Factset Research Systems Is Not A Cheap Stock

Looking at Factset Research Systems from the value perspective it is not cheap. The stock trades about 30X its earnings and at a multiple well-above the broad market but there is a reason. This stock is a powerhouse of cash generation, has blue-chip business investors want to own, and an incredibly safe (and growing) dividend. The only negative is the yield which is sub-1% but match it up with a 21-year history of distribution increase, a 13% 5-year CAGR, a 28% payout ratio, and a fortress balance sheet and it gets more interesting. The next increase is due in the 2nd calendar quarter of 2021.

The Technical Outlook: Moving Up, Possibly Range-Bound

Shares of FDS staged a solid rebound from the March lows moving up to set a new 2021 and all-time-high in the process. Since then, price action has been trapped within a range but that may be about to change. The Q1 news is good and should support upward drift if not outright bullish activity. The price action is above the short-term moving average where investors should expect at least some buying. If support confirms at this level price action may move up to the $360 level, a break about there would be bullish.

Factset Research Systems (NYSE:FDS) Could Still Be A Buy For Contrarian Investors

Should you invest $1,000 in FactSet Research Systems right now?

Before you consider FactSet Research Systems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FactSet Research Systems wasn't on the list.

While FactSet Research Systems currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
FactSet Research Systems (FDS)
2.6215 of 5 stars
$374.16+0.5%0.88%34.39Hold$436.33
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.